These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7625373)

  • 1. Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
    Clark JL; Küçük O; Neuberg DS; Benson AB; Taylor SG; Pandya KJ; Mansour EG; Douglass HO; Haller DG
    Am J Clin Oncol; 1995 Aug; 18(4):318-24. PubMed ID: 7625373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.
    Içli F; Karaoguz H; Akbulut H; Dinçol D; Demirkazik A; Cay F
    J Surg Oncol; 1997 Apr; 64(4):318-23. PubMed ID: 9142190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
    Sparano JA; Schwartz EL; Salva KM; Pizzillo MF; Wadler S; Wiernik PH
    Am J Clin Oncol; 1990 Oct; 13(5):374-8. PubMed ID: 2220657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group.
    Bajetta E; Di Bartolomeo M; de Braud F; Bozzetti F; Bochicchio AM; Comella P; Fagnani D; Farina G; Ferroni C; Franchi R
    Eur J Cancer; 1994; 30A(5):596-600. PubMed ID: 8080673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules.
    Haim N; Tsalik M; Robinson E
    Oncology; 1994; 51(1):102-7. PubMed ID: 8265093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancer.
    Scarpellini M; Tononi A; Pasquini E; Oliverio G; Fattori PP; Gianni L; Desiderio F; Nicolini M; Ravaioli A
    J Chemother; 1994 Jun; 6(3):211-5. PubMed ID: 7983505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
    Lerner A; Gonin R; Steele GD; Mayer RJ
    J Clin Oncol; 1992 Apr; 10(4):536-40. PubMed ID: 1548518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.
    Gebbia V; Valenza R; Testa A; Sciume C; Longo A; Cipolla C; Borsellino N; Leo P; Latteri M; Florena M
    J Cancer Res Clin Oncol; 1994; 120(9):550-2. PubMed ID: 8045920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
    Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
    J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
    Wang X; Pang L; Feng J
    Am J Clin Oncol; 2002 Feb; 25(1):71-5. PubMed ID: 11823701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study.
    Yeh KH; Cheng AL; Chen YC; Chen BR; Lee WJ; Lin JT; Lee PH; Chang KJ; Wang CH; Wang TH
    J Formos Med Assoc; 1994 Jan; 93(1):20-4. PubMed ID: 7915575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
    Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)".
    Räth U; Flechtner H; Selbach J; Harjung H; Manegold C; Kabelitz K; Trux FA; Edler L; Schlag P; Queisser W
    Onkologie; 1990 Jun; 13(3):194-7. PubMed ID: 2204005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
    Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
    J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
    Bjarnason GA; Cripps C; Goel R; Fine S; Oza AM; Skillings JR; Kerr I; Germond CJ; Moore MJ; Maroun JA; Franssen E; Dulude H
    Am J Clin Oncol; 1998 Dec; 21(6):537-42. PubMed ID: 9856651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK).
    Roth AD; Herrmann R; Morant R; Borner MM; Honegger HP; Obrist R; Bacchi M; Lange J; Alberto P; Castiglione M
    Eur J Cancer; 1998 Dec; 34(13):2126-8. PubMed ID: 10070322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the treatment of gastric carcinoma.
    Wilke H; Preusser P; Fink U; Achterrath W; Meyer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Geerlings H
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):61-70. PubMed ID: 2305269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction.
    Bar Sela G; Tsalic M; Gaitini D; Steiner M; Haim N
    J Chemother; 2002 Dec; 14(6):623-6. PubMed ID: 12583555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.